Safety profile of apalutamide in prostate cancer: a pooled analysis of phase III trials and the under-recognized need for real-world thyroid monitoring
Publication date: Available online 12 September 2026 Source: Prostate International Author(s): Won Tae Kim, Nam Sook Kang, Jung-Woo Chae, Soyoung Lee, Hwi-Yeol Yun, Young Joon Byun, Xuan-Mei Piao, Sun Kyu Kim, Kyeong Kim, Seok Joong Yun, Sung Kyu Hong, Jae Young Joung
Safety profile of apalutamide in prostate cancer: a pooled analysis of phase III trials and the under-recognized need for real-world thyroid monitoring. // Prostate International. – URL: https://www.sciencedirect.com/science/article/pii/S2287888226000711?dgcid=rss_sd_all
Safety profile of apalutamide in prostate cancer: a pooled analysis of phase III trials and the under-recognized need for real-world thyroid monitoring. Prostate International. https://www.sciencedirect.com/science/article/pii/S2287888226000711?dgcid=rss_sd_all
“Safety profile of apalutamide in prostate cancer: a pooled analysis of phase III trials and the under-recognized need for real-world thyroid monitoring.” Prostate International.
@article{article63205,
title = {Safety profile of apalutamide in prostate cancer: a pooled analysis of phase III trials and the under-recognized need for real-world thyroid monitoring},
journal = {Prostate International},
url = {https://www.sciencedirect.com/science/article/pii/S2287888226000711?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...